Stephan Walcher

559 total citations
15 papers, 396 citations indexed

About

Stephan Walcher is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Stephan Walcher has authored 15 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Public Health, Environmental and Occupational Health and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Stephan Walcher's work include Opioid Use Disorder Treatment (9 papers), Hepatitis B Virus Studies (4 papers) and Prenatal Substance Exposure Effects (4 papers). Stephan Walcher is often cited by papers focused on Opioid Use Disorder Treatment (9 papers), Hepatitis B Virus Studies (4 papers) and Prenatal Substance Exposure Effects (4 papers). Stephan Walcher collaborates with scholars based in Germany, Italy and Spain. Stephan Walcher's co-authors include Lorenzo Somaini, Marta Torrens, Jens Reimer, Uwe Verthein, Richard Littlewood, Markus Backmund, Thilo Beck, Christian Ruckes, Christian Haasen and Alain H. Litwin and has published in prestigious journals such as Addiction, BMC Public Health and The Annals of Thoracic Surgery.

In The Last Decade

Stephan Walcher

15 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephan Walcher Germany 10 214 197 102 52 43 15 396
Mark McLean Canada 10 172 0.8× 140 0.7× 68 0.7× 38 0.7× 14 0.3× 19 337
Elise Bailey United States 6 118 0.6× 254 1.3× 35 0.3× 117 2.3× 70 1.6× 7 433
Jeffrey McPheeters United States 8 443 2.1× 556 2.8× 24 0.2× 69 1.3× 35 0.8× 21 700
Emily Behar United States 13 303 1.4× 535 2.7× 19 0.2× 195 3.8× 37 0.9× 18 610
Jeffrey P. Hau Canada 8 56 0.3× 120 0.6× 11 0.1× 65 1.3× 34 0.8× 16 243
B Herd United Kingdom 9 88 0.4× 74 0.4× 26 0.3× 17 0.3× 30 0.7× 13 378
Joseph H. Donroe United States 9 120 0.6× 177 0.9× 5 0.0× 46 0.9× 19 0.4× 19 298
Oliver L. Hung United States 11 58 0.3× 75 0.4× 6 0.1× 27 0.5× 55 1.3× 21 489
Nancy White Australia 12 226 1.1× 236 1.2× 5 0.0× 73 1.4× 87 2.0× 20 433
Rupinder Brar Canada 12 217 1.0× 254 1.3× 3 0.0× 76 1.5× 35 0.8× 34 525

Countries citing papers authored by Stephan Walcher

Since Specialization
Citations

This map shows the geographic impact of Stephan Walcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Walcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Walcher more than expected).

Fields of papers citing papers by Stephan Walcher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Walcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Walcher. The network helps show where Stephan Walcher may publish in the future.

Co-authorship network of co-authors of Stephan Walcher

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Walcher. A scholar is included among the top collaborators of Stephan Walcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Walcher. Stephan Walcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Maremmani, Icro, Maurice Demattéis, Edward Jacek Gorzelańczyk, et al.. (2023). Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder. Journal of Clinical Medicine. 12(17). 5575–5575. 8 indexed citations
2.
Kühn, Silke, Cinzia Baschirotto, Stephan Walcher, et al.. (2021). Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine. Journal of Substance Abuse Treatment. 127. 108350–108350. 4 indexed citations
3.
Sarrazin, Christoph, Christoph Boesecke, Francesco Negro, et al.. (2021). Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal. Health Science Reports. 4(2). e290–e290. 9 indexed citations
4.
Stöver, Heino, A Marco, Richard Littlewood, et al.. (2019). Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe. BMC Public Health. 19(1). 30–30. 31 indexed citations
5.
Litwin, Alain H., Chizoba Nwankwo, Marta Torrens, et al.. (2019). Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C‐SCOPE Study. Journal of Viral Hepatitis. 26(9). 1094–1104. 50 indexed citations
6.
Grebely, Jason, Chizoba Nwankwo, Marta Torrens, et al.. (2018). Perceptions and self-reported competency related to testing, management and treatment of hepatitis C virus infection among physicians prescribing opioid agonist treatment: The C-SCOPE study. International Journal of Drug Policy. 63. 29–38. 18 indexed citations
7.
Krause, Daniela, Gabriele Koller, C. A. Winter, et al.. (2017). High Concomitant Misuse of Fentanyl in Subjects on Opioid Maintenance Treatment. Substance Use & Misuse. 52(5). 639–645. 11 indexed citations
8.
Demattéis, Maurice, Marc Auriacombe, Oscar D’Agnone, et al.. (2017). Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus. Expert Opinion on Pharmacotherapy. 18(18). 1987–1999. 94 indexed citations
9.
Walcher, Stephan, et al.. (2016). The opiate dosage adequacy scale for identification of the right methadone dose—a prospective cohort study. BMC Pharmacology and Toxicology. 17(1). 15–15. 8 indexed citations
10.
Reimer, Jens, et al.. (2014). When higher doses in opioid replacement treatment are still inadequate – association to multidimensional illness severity: a cohort study. Substance Abuse Treatment Prevention and Policy. 9(1). 13–13. 13 indexed citations
11.
Reimer, Jens, et al.. (2014). OR06-5 * WHEN HIGHER DOSES IN OPIOID REPLACEMENT TREATMENT ARE STILL INADEQUATE - ASSOCIATION TO MULTIDIMENSIONAL ILLNESS SEVERITY: A COHORT STUDY. Alcohol and Alcoholism. 49(suppl 1). i44–i44. 5 indexed citations
12.
Beck, Thilo, Christian Haasen, Uwe Verthein, et al.. (2013). Maintenance treatment for opioid dependence with slow‐release oral morphine: a randomized cross‐over, non‐inferiority study versus methadone. Addiction. 109(4). 617–626. 67 indexed citations
13.
14.
Tretter, Felix, et al.. (1998). Clinical experience with antagonist‐induced opiate withdrawal under anaesthesia. Addiction. 93(2). 269–275. 29 indexed citations
15.
Feindt, P., Stephan Walcher, I. Volkmer, et al.. (1995). Effects of high-dose aprotinin on renal function in aortocoronary bypass grafting. The Annals of Thoracic Surgery. 60(4). 1076–1080. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark McLean Breakdown of academic impact, for papers by Elise Bailey Breakdown of academic impact, for papers by Jeffrey McPheeters Breakdown of academic impact, for papers by Emily Behar Breakdown of academic impact, for papers by Jeffrey P. Hau Breakdown of academic impact, for papers by B Herd Breakdown of academic impact, for papers by Joseph H. Donroe Breakdown of academic impact, for papers by Oliver L. Hung Breakdown of academic impact, for papers by Nancy White Breakdown of academic impact, for papers by Rupinder Brar
Rankless by CCL
2026